Cooper Cos Inc-The logo

Cooper Cos Inc-The (COO)

Market Closed
30 Apr, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
81. 67
-0.56
-0.68%
$
20.51B Market Cap
- P/E Ratio
0.12% Div Yield
1,485,809 Volume
- Eps
$ 82.23
Previous Close
Day Range
79.86 81.85
Year Range
69.81 112.38
Earnings results expected in 28 days

Summary

COO closed today lower at $81.67, a decrease of 0.68% from yesterday's close, completing a monthly decrease of -2.99% or $2.52. Over the past 12 months, COO stock lost -11.77%.
COO pays dividends to its shareholders, with the most recent payment made on Aug 11, 2023. The next estimated payment will be in 11 Aug 2023 on Aug 11, 2023 for a total of $0.0075.
The last earnings report, released on Feb 26, 2025, exceeded the consensus estimates by 0.01%. On average, the company has surpassed earnings expectations by 0.03%, based on the last three reports. The next scheduled earnings report is due on May 28, 2025.
Cooper Cos Inc-The has completed 1 stock splits, with the recent split occurring on Feb 20, 2024.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
Want to track COO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

COO Chart

CooperCompanies Appoints Barbara Carbone to Board of Directors

CooperCompanies Appoints Barbara Carbone to Board of Directors

SAN RAMON, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its Board of Directors has appointed Barbara Carbone as an independent director, effective May 1, 2025. Ms. Carbone has also been appointed to serve on the Audit Committee when she joins the Board.

Globenewswire | 3 hours ago
CooperCompanies Announces Release Date for Second Quarter 2025

CooperCompanies Announces Release Date for Second Quarter 2025

SAN RAMON, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report second quarter 2025 financial results on Thursday, May 29, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

Globenewswire | 1 day ago
Encompass Health announces promotion of Patrick Tuer to newly established COO position

Encompass Health announces promotion of Patrick Tuer to newly established COO position

BIRMINGHAM, Ala. , April 24, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the promotion of Patrick Tuer from group president to the newly established position of chief operating officer (COO), effective immediately.

Prnewswire | 6 days ago

Cooper Cos Inc-The (COO) FAQ

What is the stock price today?

The current price is $81.67.

On which exchange is it traded?

Cooper Cos Inc-The is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is COO.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 20.51B.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on May 28, 2025.

Has Cooper Cos Inc-The ever had a stock split?

Cooper Cos Inc-The had 1 splits and the recent split was on Feb 20, 2024.

Cooper Cos Inc-The Profile

Medical Instruments & Supplies Industry
Healthcare Sector
Mr. Albert G. White III CEO
NASDAQ (NGS) Exchange
US2166484020 ISIN
United States Country
15,000 Employees
26 Jul 2023 Last Dividend
20 Feb 2024 Last Split
- IPO Date

Overview

The Cooper Companies, Inc., established in 1958 and headquartered in San Ramon, California, is a global entity that specializes in the development, manufacture, and marketing of contact lenses through its subsidiaries. The operations of the company are segmented into CooperVision and CooperSurgical. CooperVision focuses on providing a variety of contact lenses including those for correcting nearsightedness, farsightedness, astigmatism, presbyopia, and myopia across various regions such as the Americas, Europe, Middle East, Africa, and Asia Pacific. On the other hand, CooperSurgical addresses family and women's health, offering a wide range of fertility products and services, medical devices, contraception, and cryostorage services for cord blood and tissue to healthcare professionals and patients globally. The products offered by The Cooper Companies, Inc. reach their end-users through distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals, clinics, and authorized resellers.

Products and Services

CooperVision:

  • Spherical Lenses: These lenses are designed to correct common vision problems such as nearsightedness and farsightedness.
  • Toric and Multifocal Lenses: These lenses provide solutions for more complex vision challenges, including astigmatism, presbyopia, and myopia, catering to a diverse range of contact lens wearers.

CooperSurgical:

  • Fertility Products and Services: Includes consumables, equipment, donor gamete services, and genomic services such as genetic testing, designed to support the varying needs of fertility treatments.
  • Medical Devices and Contraception: Ranging from Paragard contraceptive IUDs, endosee endometrial imaging, and Mara water ablation systems, these products aim to provide innovative solutions in women's healthcare and family planning.
  • Cryostorage Services: Offering storage solutions for cord blood and tissue, these services play a crucial role in regenerative medicine and future health considerations.
  • Surgical and Office Products: This encompasses a broad spectrum of devices and tools such as illuminated speculum products, lone star retractor systems, and fetal pillow cephalic elevation devices, used across gynecological procedures and office-based diagnostics.

Contact Information

Address: 6101 Bollinger Canyon Road
Phone: 925 460 3600